Gene-environment interactions in the aetiology of systemic lupus erythematosus.
Systemic lupus erythematosus (SLE) is a disease that displays a multitude of symptoms and a vast array of autoantibodies. The disease course may vary substantially between patients. The current understanding of SLE aetiology includes environmental factors acting on a genetically prone individual during an undetermined time period resulting in autoimmunity and finally surpassing that individual's disease threshold. Genetic differences and environmental factors may interact specifically in the pathogenetic processes and may influence disease development and modify the disease course. Identification of these factors and their interactions in the pathogenesis of SLE is vital in understanding the disease and may contribute to identify new treatment targets and perhaps also aid in disease prevention. However, there are several problems that need to be overcome, such as the protracted time frame of environmental influence, time dependent epigenetic alterations and the possibility that different pathogenetic pathways may result in a similar disease phenotype. This is mirrored by the relatively few studies that suggest specific gene-environment interactions. These include an association between SLE diagnosis and glutation S-transferase gene variants combined with occupational sun exposure as well as variants of the N-acetyl transferase gene in combination with either aromatic amine exposure or hydralazine. With increased knowledge on SLE pathogenesis, the role of environmental factors and their genetic interactions may be further elucidated.
Jönsen
Andreas
A
Section of Rheumatology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Bengtsson
Anders A
AA
Nived
Ola
O
Truedsson
Lennart
L
Sturfelt
Gunnar
G
D001191:Arylamine N-Acetyltransferase / Q000235:genetics / Q000276:immunology; D001323:Autoantibodies / Q000235:genetics / Q000276:immunology; D004777:Environment; D044127:Epigenesis, Genetic / Q000276:immunology; D020022:Genetic Predisposition to Disease; D005982:Glutathione Transferase / Q000235:genetics / Q000276:immunology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000201:enzymology / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D016273:Occupational Exposure / Q000009:adverse effects*; D010641:Phenotype; D013472:Sunlight / Q000009:adverse effects*
D001323:Autoantibodies; D001191:Arylamine N-Acetyltransferase; D005982:Glutathione Transferase